Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	The Angels Initiative Stroke prevention

Tuberculosis

Free Subscription 23.05.2022 3 Am J Respir Crit Care Med 1 Antimicrob Agents Chemother 1 BMJ 1 Clin Exp Immunol 1 Clin Infect Dis 3 Eur Respir J 2 J Infect 4 PLoS One

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Am J Respir Crit Care Med

1. DINKELE R, Gessner S, McKerry A, Leonard B, et al
   Aerosolization of Mycobacterium tuberculosis by Tidal Breathing.
   Am J Respir Crit Care Med. 2022 May 18. doi: 10.1164/rccm.202110-2378.
   PubMed         Abstract available
   
   
2. DE JAGER V, Gupte N, Nunes S, Barnes GL, et al
   Early Bactericidal Activity of Meropenem plus Clavulanate (with or without Rifampin) for Tuberculosis: The COMRADE Randomized, Phase 2A Clinical Trial.
   Am J Respir Crit Care Med. 2022;205:1228-1235.
   PubMed         Abstract available
   
   
3. ESMAIL A, Oelofse S, Lombard C, Perumal R, et al
   An All-Oral 6-Month Regimen for Multidrug-Resistant Tuberculosis: A Multicenter, Randomized Controlled Clinical Trial (the NExT Study).
   Am J Respir Crit Care Med. 2022;205:1214-1227.
   PubMed         Abstract available
   
   

   
   Antimicrob Agents Chemother

4. PAUL A, Nair RR, Jakkala K, Pradhan A, et al
   Elevated Levels of Three Reactive Oxygen Species and Fe(II) in the Antibiotic-Surviving Population of Mycobacteria Facilitate De Novo Emergence of Genetic Resisters to Antibiotics.
   Antimicrob Agents Chemother. 2022;66:e0228521.
   PubMed         Abstract available
   
   

   
   BMJ

5. SPENDER Q
   Private practitioners should treat, not just assess.
   BMJ. 2022;377:o1247.
   PubMed        
   
   

   
   Clin Exp Immunol

6. ESMAEL A, Abebe T, Mihret A, Mussa D, et al
   Mycobacterium tuberculosis antigen-specific T cell responses in smear- negative pulmonary tuberculosis patients.
   Clin Exp Immunol. 2022 May 12. pii: 6585020. doi: 10.1093.
   PubMed         Abstract available
   
   

   
   Clin Infect Dis

7. COX H, Workman L, Bateman L, Franckling-Smith Z, et al
   Oral swabs tested with Xpert MTB/RIF Ultra for diagnosis of pulmonary tuberculosis in children: a diagnostic accuracy study.
   Clin Infect Dis. 2022 May 17. pii: 6586837. doi: 10.1093.
   PubMed         Abstract available
   
   

   
   Eur Respir J

8. AHMED M, Tezera LB, Elkington PT, Leslie AJ, et al
   The paradox of immune checkpoint inhibition reactivating tuberculosis.
   Eur Respir J. 2022 May 20. pii: 13993003.02512-2021.
   PubMed         Abstract available
   
   
9. GUGLIELMETTI L, Gunther G, Leu C, Cirillo D, et al
   Rifapentine access in Europe: growing concerns over key tuberculosis treatment component.
   Eur Respir J. 2022;59.
   PubMed        
   
   
10. SPRUIJT I, Joren C, Schimmel H, Procee F, et al
    The identification of prevalent tuberculosis disease through infection screening among high-risk migrants in the Netherlands.
    Eur Respir J. 2022;59.
    PubMed        
    
    

    
    J Infect

11. WYLLIE D, Do T, Myers R, Nikolayevskyy V, et al
    M. tuberculosis microvariation is common and is associated with transmission: analysis of three years prospective universal sequencing in England.
    J Infect. 2022 May 17. pii: S0163-4453(22)00294.
    PubMed         Abstract available
    
    
12. CHEN Y, Liu Q, Takiff HE, Gao Q, et al
    Comprehensive genomic analysis of Mycobacterium tuberculosis reveals limited impact of high-fitness genotypes on MDR-TB transmission.
    J Infect. 2022 May 16. pii: S0163-4453(22)00293.
    PubMed         Abstract available
    
    

    
    PLoS One

13. DELGADO LG, Postigo M, Cuadrado D, Gil-Casanova S, et al
    Remote analysis of sputum smears for mycobacterium tuberculosis quantification using digital crowdsourcing.
    PLoS One. 2022;17:e0268494.
    PubMed         Abstract available
    
    
14. PEPIN J, Desjardins F, Carignan A, Lambert M, et al
    Impact and benefit-cost ratio of a program for the management of latent tuberculosis infection among refugees in a region of Canada.
    PLoS One. 2022;17:e0267781.
    PubMed         Abstract available
    
    
15. KAZIBWE A, Oryokot B, Mugenyi L, Kagimu D, et al
    Incidence of tuberculosis among PLHIV on antiretroviral therapy who initiated isoniazid preventive therapy: A multi-center retrospective cohort study.
    PLoS One. 2022;17:e0266285.
    PubMed         Abstract available
    
    
16. SALOMON A, Law S, Johnson C, Baddeley A, et al
    Interventions to improve linkage along the HIV-tuberculosis care cascades in low- and middle-income countries: A systematic review and meta-analysis.
    PLoS One. 2022;17:e0267511.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Tuberculosis is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: